This inventor holds 1 USPTO granted patent. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Frederic Tremblay: Innovator in RNA Therapeutics
Introduction
Frederic Tremblay is a notable inventor based in Cambridge, Canada. He has made significant contributions to the field of RNA therapeutics, particularly through his work at Alnylam Pharmaceuticals, Inc. His innovative approach has led to advancements in medical treatments.
Latest Patents
Frederic Tremblay holds a patent for "APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF." This patent represents a crucial development in the understanding and application of RNA interference technology.
Career Highlights
Throughout his career, Frederic has focused on the intersection of biotechnology and medicine. His work at Alnylam Pharmaceuticals, Inc. has positioned him as a key player in the development of RNA-based therapies. He has demonstrated a commitment to advancing healthcare through innovative solutions.
Collaborations
Frederic has collaborated with talented individuals such as James D McIninch and Adam Castoreno. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Frederic Tremblay's contributions to RNA therapeutics exemplify the impact of innovation in medicine. His work continues to inspire advancements in the field, paving the way for future breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile